ConMed Corp. (NYSE: CNMD), a surgical-device maker with roots in the Utica area, has announced that its board of directors declared a quarterly cash dividend of 20 cents a share for the fourth quarter of 2022. The dividend is payable on Jan. 5 to all shareholders of record as of Dec. 16. At the company’s […]
Get Instant Access to This Article
Become a Central New York Business Journal subscriber and get immediate access to all of our subscriber-only content and much more.
- Critical Central New York business news and analysis updated daily.
- Immediate access to all subscriber-only content on our website.
- Get a year's worth of the Print Edition of The Central New York Business Journal.
- Special Feature Publications such as the Book of Lists and Revitalize Greater Binghamton, Mohawk Valley, and Syracuse Magazines
Click here to purchase a paywall bypass link for this article.
ConMed Corp. (NYSE: CNMD), a surgical-device maker with roots in the Utica area, has announced that its board of directors declared a quarterly cash dividend of 20 cents a share for the fourth quarter of 2022.
The dividend is payable on Jan. 5 to all shareholders of record as of Dec. 16. At the company’s current stock price, the dividend yields less than 1 percent on an annual basis.
ConMed manufactures surgical devices and equipment for minimally invasive procedures. The company’s products are used by surgeons and physicians in specialties that include orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology.
ConMed, which was headquartered in the Utica–Rome region for more than 50 years, at the beginning of 2021 designated Largo, Florida (in the Tampa Bay area) as its corporate headquarters Its Utica–area facility is located at 525 French Road in New Hartford, where the company continues to maintain its manufacturing, finance, human resources, legal, and other corporate functions. The Florida office houses its CEO and other key executives.